BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Berliner JL, Fay AM, Cummings SA, Burnett B, Tillmanns T. NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer. J Genet Couns. 2013;22:155-163. [PMID: 23188549 DOI: 10.1007/s10897-012-9547-1] [Cited by in Crossref: 92] [Cited by in F6Publishing: 68] [Article Influence: 9.2] [Reference Citation Analysis]
Number Citing Articles
1 Di Gioacchino V, Langlois S, Elliott AM. Canadian genetic healthcare professionals' attitudes towards discussing private pay options with patients. Mol Genet Genomic Med 2019;7:e00572. [PMID: 30712332 DOI: 10.1002/mgg3.572] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Scherr CL, Lindor NM, Malo TL, Couch FJ, Vadaparampil ST. A preliminary investigation of genetic counselors' information needs when receiving a variant of uncertain significance result: a mixed methods study. Genet Med 2015;17:739-46. [PMID: 25569439 DOI: 10.1038/gim.2014.185] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
3 Cragun D, Scherr C, Camperlengo L, Vadaparampil ST, Pal T. Evolution of Hereditary Breast Cancer Genetic Services: Are Changes Reflected in the Knowledge and Clinical Practices of Florida Providers? Genet Test Mol Biomarkers 2016;20:569-78. [PMID: 27525501 DOI: 10.1089/gtmb.2016.0113] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
4 Green RF, Ari M, Kolor K, Dotson WD, Bowen S, Habarta N, Rodriguez JL, Richardson LC, Khoury MJ. Evaluating the role of public health in implementation of genomics-related recommendations: a case study of hereditary cancers using the CDC Science Impact Framework. Genet Med 2019;21:28-37. [PMID: 29907802 DOI: 10.1038/s41436-018-0028-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
5 Mets S, Tryon R, Veach PM, Zierhut HA. Genetic Counselors' Experiences Regarding Communication of Reproductive Risks with Autosomal Recessive Conditions found on Cancer Panels. J Genet Couns 2016;25:359-72. [PMID: 26454646 DOI: 10.1007/s10897-015-9892-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 LaDuca H, Stuenkel AJ, Dolinsky JS, Keiles S, Tandy S, Pesaran T, Chen E, Gau CL, Palmaer E, Shoaepour K. Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients. Genet Med. 2014;16:830-837. [PMID: 24763289 DOI: 10.1038/gim.2014.40] [Cited by in Crossref: 217] [Cited by in F6Publishing: 190] [Article Influence: 27.1] [Reference Citation Analysis]
7 Knerr S, West KM, Angelo FA. Organizational readiness to implement population-based screening and genetic service delivery for hereditary cancer prevention and control. J Genet Couns 2020;29:867-76. [PMID: 31967362 DOI: 10.1002/jgc4.1216] [Reference Citation Analysis]
8 Interrante MK, Segal H, Peshkin BN, Valdimarsdottir HB, Nusbaum R, Similuk M, DeMarco T, Hooker G, Graves K, Isaacs C, Wood M, McKinnon W, Garber J, McCormick S, Heinzmann J, Kinney AY, Schwartz MD. Randomized Noninferiority Trial of Telephone vs In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer: A 12-Month Follow-Up. JNCI Cancer Spectr 2017;1:pkx002. [PMID: 31304457 DOI: 10.1093/jncics/pkx002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
9 Roberts MC, Dusetzina SB. The effect of a celebrity health disclosure on demand for health care: trends in BRCA testing and subsequent health services use. J Community Genet 2017;8:141-6. [PMID: 28299592 DOI: 10.1007/s12687-017-0295-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
10 Lang KA. Genetic counseling for breast cancer risk: how did we get here and where are we going? Expert Rev Mol Diagn 2013;13:541-51. [PMID: 23895125 DOI: 10.1586/14737159.2013.811903] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
11 Madlensky L. Is it time to embrace telephone genetic counseling in the oncology setting? J Clin Oncol 2014;32:611-2. [PMID: 24449232 DOI: 10.1200/JCO.2013.53.8975] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
12 Haga SB, Mills R. A review of consent practices and perspectives for pharmacogenetic testing. Pharmacogenomics 2016;17:1595-605. [PMID: 27533720 DOI: 10.2217/pgs-2016-0039] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
13 Eggert J. Genetics and Genomics in Oncology Nursing: What Does Every Nurse Need to Know? Nurs Clin North Am 2017;52:1-25. [PMID: 28189157 DOI: 10.1016/j.cnur.2016.11.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Toss A, Quarello P, Mascarin M, Banna GL, Zecca M, Cinieri S, Peccatori FA, Ferrari A. Cancer Predisposition Genes in Adolescents and Young Adults (AYAs): a Review Paper from the Italian AYA Working Group. Curr Oncol Rep 2022. [PMID: 35320498 DOI: 10.1007/s11912-022-01213-3] [Reference Citation Analysis]
15 Underhill ML, Crotser CB. Seeking balance: decision support needs of women without cancer and a deleterious BRCA1 or BRCA2 mutation. J Genet Couns 2014;23:350-62. [PMID: 24271037 DOI: 10.1007/s10897-013-9667-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
16 Goetsch AL, Wicklund C, Clayman ML, Woodruff TK. Reproductive Endocrinologists' Utilization of Genetic Counselors for Oncofertility and Preimplantation Genetic Diagnosis (PGD) Treatment of BRCA1/2 Mutation Carriers. J Genet Couns 2016;25:561-71. [PMID: 26567039 DOI: 10.1007/s10897-015-9908-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
17 Hippman C, Nislow C. Pharmacogenomic Testing: Clinical Evidence and Implementation Challenges. J Pers Med 2019;9:E40. [PMID: 31394823 DOI: 10.3390/jpm9030040] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
18 Mahon SM. Risk Assessment, Prevention, and Early Detection: Challenges for the Advanced Practice Nurse. Seminars in Oncology Nursing 2015;31:306-26. [DOI: 10.1016/j.soncn.2015.08.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
19 Lang GT, Shi JX, Hu X, Zhang CH, Shan L, Song CG, Zhuang ZG, Cao AY, Ling H, Yu KD, Li S, Sun MH, Zhou XY, Huang W, Shao ZM. The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next-generation sequencing. Int J Cancer 2017;141:129-42. [PMID: 28294317 DOI: 10.1002/ijc.30692] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 8.4] [Reference Citation Analysis]
20 Hiraki S, Rinella ES, Schnabel F, Oratz R, Ostrer H. Cancer risk assessment using genetic panel testing: considerations for clinical application. J Genet Couns 2014;23:604-17. [PMID: 24599651 DOI: 10.1007/s10897-014-9695-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
21 Lagarde JBB, Laurino MY, San Juan MD, Cauyan JML, Tumulak MJR, Ventura ER. Risk perception and screening behavior of Filipino women at risk for breast cancer: implications for cancer genetic counseling. J Community Genet 2019;10:281-9. [PMID: 30259342 DOI: 10.1007/s12687-018-0391-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Borzekowski DL, Guan Y, Smith KC, Erby LH, Roter DL. The Angelina effect: immediate reach, grasp, and impact of going public. Genet Med 2014;16:516-21. [PMID: 24357847 DOI: 10.1038/gim.2013.181] [Cited by in Crossref: 91] [Cited by in F6Publishing: 78] [Article Influence: 10.1] [Reference Citation Analysis]
23 Chen Z, Kolor K, Grosse SD, Rodriguez JL, Lynch JA, Green RF, Dotson WD, Bowen MS, Khoury MJ. Trends in utilization and costs of BRCA testing among women aged 18-64 years in the United States, 2003-2014. Genet Med 2018;20:428-34. [PMID: 28933789 DOI: 10.1038/gim.2017.118] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
24 Sie AS, Spruijt L, van Zelst-Stams WA, Mensenkamp AR, Ligtenberg MJ, Brunner HG, Prins JB, Hoogerbrugge N. High Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic Counseling. J Genet Couns 2016;25:504-14. [PMID: 26531312 DOI: 10.1007/s10897-015-9899-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
25 Kelly KM, Ellington L, Schoenberg N, Agarwal P, Jackson T, Dickinson S, Abraham J, Paskett ED, Leventhal H, Andrykowski M. Linking genetic counseling content to short-term outcomes in individuals at elevated breast cancer risk. J Genet Couns 2014;23:838-48. [PMID: 24671341 DOI: 10.1007/s10897-014-9705-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
26 Fanale D, Pivetti A, Cancelliere D, Spera A, Bono M, Fiorino A, Pedone E, Barraco N, Brando C, Perez A, Guarneri MF, Russo TDB, Vieni S, Guarneri G, Russo A, Bazan V. BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: looking for the hidden meaning. Crit Rev Oncol Hematol 2022;:103626. [PMID: 35150867 DOI: 10.1016/j.critrevonc.2022.103626] [Reference Citation Analysis]
27 Neff RT, Senter L, Salani R. BRCA mutation in ovarian cancer: testing, implications and treatment considerations. Ther Adv Med Oncol 2017;9:519-31. [PMID: 28794804 DOI: 10.1177/1758834017714993] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 8.2] [Reference Citation Analysis]
28 Fashoyin-Aje L, Sanghavi K, Bjornard K, Bodurtha J. Integrating genetic and genomic information into effective cancer care in diverse populations. Ann Oncol 2013;24 Suppl 7:vii48-54. [PMID: 24001763 DOI: 10.1093/annonc/mdt264] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
29 Sharma P, Klemp JR, Kimler BF, Mahnken JD, Geier LJ, Khan QJ, Elia M, Connor CS, McGinness MK, Mammen JM, Wagner JL, Ward C, Ranallo L, Knight CJ, Stecklein SR, Jensen RA, Fabian CJ, Godwin AK. Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing. Breast Cancer Res Treat 2014;145:707-14. [PMID: 24807107 DOI: 10.1007/s10549-014-2980-0] [Cited by in Crossref: 91] [Cited by in F6Publishing: 88] [Article Influence: 11.4] [Reference Citation Analysis]
30 Scherr CL, Christie J, Vadaparampil ST. Breast Cancer Survivors' Knowledge of Hereditary Breast and Ovarian Cancer following Genetic Counseling: An Exploration of General and Survivor-Specific Knowledge Items. Public Health Genomics 2016;19:1-10. [PMID: 26389838 DOI: 10.1159/000439162] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
31 Szender JB, Kaur J, Clayback K, Hutton ML, Mikkelson J, Odunsi K, Dresbold C. Breadth of Genetic Testing Selected by Patients at Risk of Hereditary Breast and Ovarian Cancer. Int J Gynecol Cancer 2018;28:26-33. [PMID: 28930807 DOI: 10.1097/IGC.0000000000001122] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
32 Hessock M, Brewer T, Hutson S, Anderson J. Use of a Standardized Tool to Identify Women at Risk for Hereditary Breast and Ovarian. Nurs Womens Health 2021;25:187-97. [PMID: 33933425 DOI: 10.1016/j.nwh.2021.03.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Stanislaw C, Xue Y, Wilcox WR. Genetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing. Cancer Biol Med 2016;13:55-67. [PMID: 27144062 DOI: 10.28092/j.issn.2095-3941.2016.0002] [Cited by in F6Publishing: 22] [Reference Citation Analysis]
34 Sayani A. Inequities in genetic testing for hereditary breast cancer: implications for public health practice. J Community Genet 2019;10:35-9. [PMID: 29781042 DOI: 10.1007/s12687-018-0370-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
35 McCuaig JM, Stockley TL, Shaw P, Fung-Kee-Fung M, Altman AD, Bentley J, Bernardini MQ, Cormier B, Hirte H, Kieser K, MacMillan A, Meschino WS, Panabaker K, Perrier R, Provencher D, Schrader KA, Serfas K, Tomiak E, Wong N, Young SS, Gotlieb WH, Hoskins P, Kim RH; BRCA TtoT Community of Practice. Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmap. J Med Genet 2018;55:571-7. [PMID: 30042185 DOI: 10.1136/jmedgenet-2018-105472] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
36 Hooker GW, Clemens KR, Quillin J, Vogel Postula KJ, Summerour P, Nagy R, Buchanan AH. Cancer Genetic Counseling and Testing in an Era of Rapid Change. J Genet Couns 2017;26:1244-53. [PMID: 28434142 DOI: 10.1007/s10897-017-0099-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
37 Warias A, Ferguson M, Chamberlain E, Currie L, Snow N, Matheson K, Penney LS, Kieser K. Universal access to genetic counseling for women with epithelial ovarian cancer in Nova Scotia: Evaluating a new collaborative care model. J Genet Couns 2021. [PMID: 33876505 DOI: 10.1002/jgc4.1416] [Reference Citation Analysis]
38 Patel D, Blouch EL, Rodgers-fouché LH, Emmet MM, Shannon KM. Finding a Balance: Reconciling the Needs of the Institution, Patient, and Genetic Counselor for Optimal Resource Utilization. J Genet Counsel 2018;27:1318-27. [DOI: 10.1007/s10897-018-0270-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Lundy MG, Forman A, Valverde K, Kessler L. An investigation of genetic counselors' testing recommendations: pedigree analysis and the use of multiplex breast cancer panel testing. J Genet Couns 2014;23:618-32. [PMID: 24569857 DOI: 10.1007/s10897-014-9692-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
40 Scherr CL, Feuston JL, Nixon DM, Cohen SA. A Two-Phase Approach to Developing SNAP: an iPhone Application to Support Appointment Scheduling and Management for Women with a BRCA Mutation. J Genet Couns 2018;27:439-45. [PMID: 29423568 DOI: 10.1007/s10897-018-0222-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
41 Kanwal S, Jamil F, Ali A, Sehgal SA. Comparative Modeling, Molecular Docking, and Revealing of Potential Binding Pockets of RASSF2; a Candidate Cancer Gene. Interdiscip Sci 2017;9:214-23. [PMID: 26782783 DOI: 10.1007/s12539-016-0145-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
42 Shannon KM, Emmet MM, Rodgers LH, Wooters M, Seidel ML. Transition to telephone genetic counseling services during the COVID-19 pandemic. J Genet Couns 2021;30:984-8. [PMID: 33277765 DOI: 10.1002/jgc4.1365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
43 Tsigginou A, Vlachopoulos F, Arzimanoglou I, Zagouri F, Dimitrakakis C. Cumulative BRCA mutation analysis in the Greek population confirms that homogenous ethnic background facilitates genetic testing. Hered Cancer Clin Pract 2015;13:17. [PMID: 26300996 DOI: 10.1186/s13053-015-0037-y] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
44 Meaney-Delman D, Bellcross CA. Hereditary breast/ovarian cancer syndrome: a primer for obstetricians/gynecologists. Obstet Gynecol Clin North Am. 2013;40:475-512. [PMID: 24021253 DOI: 10.1016/j.ogc.2013.05.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
45 Zierhut HA, Tryon R, Sanborn EM. Genetic Counseling for Fanconi Anemia: Crosslinking Disciplines. J Genet Counsel 2014;23:910-21. [DOI: 10.1007/s10897-014-9754-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
46 Halbert CH, Harrison BW. Genetic counseling among minority populations in the era of precision medicine. Am J Med Genet 2018;178:68-74. [DOI: 10.1002/ajmg.c.31604] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
47 Trivedi MS, Crew KD. Implications of multigene testing for hereditary breast cancer in primary care. World J Obstet Gynecol 2016; 5(1): 50-57 [DOI: 10.5317/wjog.v5.i1.50] [Reference Citation Analysis]
48 Marie Lewis K. Identifying hereditary cancer: Genetic counseling and cancer risk assessment. Current Problems in Cancer 2014;38:216-25. [DOI: 10.1016/j.currproblcancer.2014.10.002] [Cited by in Crossref: 6] [Article Influence: 0.8] [Reference Citation Analysis]
49 Kne A, Zierhut H, Baldinger S, Swenson KK, Mink P, Veach PM, Tsai ML. Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter. J Genet Counsel 2017;26:697-715. [DOI: 10.1007/s10897-016-0040-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
50 Lara-otero K, Weil J, Guerra C, Cheng JKY, Youngblom J, Joseph G. Genetic Counselor and Healthcare Interpreter Perspectives on the Role of Interpreters in Cancer Genetic Counseling. Health Communication 2018;34:1608-18. [DOI: 10.1080/10410236.2018.1514684] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
51 Riddle L, Amendola LM, Gilmore MJ, Guerra C, Biesecker B, Kauffman TL, Anderson K, Rope AF, Leo MC, Caruncho M, Jarvik GP, Wilfond B, Goddard KAB, Joseph G. Development and early implementation of an Accessible, Relational, Inclusive and Actionable approach to genetic counseling: The ARIA model. Patient Educ Couns 2021;104:969-78. [PMID: 33549385 DOI: 10.1016/j.pec.2020.12.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
52 Quinn GP, Peshkin BN, Sehovic I, Bowman M, Tamargo C, Vadaparampil ST. Oncofertility in adolescent and young adult hereditary cancer: Considerations for genetics professionals. World J Med Genet 2015; 5(4): 52-59 [DOI: 10.5496/wjmg.v5.i4.52] [Reference Citation Analysis]
53 Hung FH, Wang YA, Jian JW, Peng HP, Hsieh LL, Hung CF, Yang MM, Yang AS. Evaluating BRCA mutation risk predictive models in a Chinese cohort in Taiwan. Sci Rep 2019;9:10229. [PMID: 31308460 DOI: 10.1038/s41598-019-46707-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
54 Phillips KA, Trosman JR, Kelley RK, Pletcher MJ, Douglas MP, Weldon CB. Genomic sequencing: assessing the health care system, policy, and big-data implications. Health Aff (Millwood) 2014;33:1246-53. [PMID: 25006153 DOI: 10.1377/hlthaff.2014.0020] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
55 Scherr CL, Ramesh S, Getachew-Smith H, Kalke K, Ramsey K, Fischhoff B, Vadaparampil ST. How patients deal with an ambiguous medical test: Decision-making after genetic testing. Patient Educ Couns 2021;104:953-9. [PMID: 33214013 DOI: 10.1016/j.pec.2020.10.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Bando H. Issues of concern in risk assessment, genetic counseling, and genetic testing of younger breast cancer patients in Japan. Breast Cancer 2014;21:656-63. [PMID: 23754181 DOI: 10.1007/s12282-013-0477-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
57 Underhill-Blazey M, Stopfer J, Chittenden A, Nayak MM, Lansang K, Lederman R, Garber J, Gundersen DA. Development and testing of the KnowGene scale to assess general cancer genetic knowledge related to multigene panel testing. Patient Educ Couns 2019;102:1558-64. [PMID: 31010603 DOI: 10.1016/j.pec.2019.04.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
58 McCuaig JM, Thain E, Malcolmson J, Keshavarzi S, Armel SR, Kim RH. A Comparison of Patient-Reported Outcomes Following Consent for Genetic Testing Using an Oncologist- or Genetic Counselor-Mediated Model of Care. Curr Oncol 2021;28:1459-71. [PMID: 33917963 DOI: 10.3390/curroncol28020138] [Reference Citation Analysis]
59 Hamilton JG, Peshkin BN, Mays D, DeMarco TA, Patenaude AF, Tercyak KP. Maternal perceptions of BRCA genetic counseling communication processes about disclosing cancer risk information to children and adult relatives. Psychooncology 2018;27:1825-32. [PMID: 29645321 DOI: 10.1002/pon.4733] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
60 Nair N, Bellcross C, Haddad L, Martin M, Matthews R, Gabram-Mendola S, Crane B, Meaney-Delman D. Georgia Primary Care Providers' Knowledge of Hereditary Breast and Ovarian Cancer Syndrome. J Cancer Educ 2017;32:119-24. [PMID: 26637472 DOI: 10.1007/s13187-015-0950-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
61 O'Neill SC, Hamilton JG, Conley CC, Peshkin BN, Sacca R, McDonnell GA, Isaacs C, Robson ME, Tercyak KP. Improving our model of cascade testing for hereditary cancer risk by leveraging patient peer support: a concept report. Hered Cancer Clin Pract 2021;19:40. [PMID: 34565430 DOI: 10.1186/s13053-021-00198-7] [Reference Citation Analysis]
62 Nair N, Schwartz M, Guzzardi L, Durlester N, Pan S, Overbey J, Chuang L. Hysterectomy at the time of risk-reducing surgery in BRCA carriers. Gynecol Oncol Rep 2018;26:71-4. [PMID: 30364812 DOI: 10.1016/j.gore.2018.10.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
63 Bellcross CA, Peipins LA, McCarty FA, Rodriguez JL, Hawkins NA, Hensley Alford S, Leadbetter S. Characteristics associated with genetic counseling referral and BRCA1/2 testing among women in a large integrated health system. Genet Med 2015;17:43-50. [PMID: 24946155 DOI: 10.1038/gim.2014.68] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
64 Himes DO, Clayton MF, Donaldson GW, Ellington L, Buys SS, Kinney AY. Breast Cancer Risk Perceptions among Relatives of Women with Uninformative Negative BRCA1/2 Test Results: The Moderating Effect of the Amount of Shared Information.J Genet Couns. 25: 258-269. [PMID: 26245632 DOI: 10.1007/s10897-015-9866-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
65 Williams LA, Quinonez SC, Uhlmann WR. The Genetics Journey: A Case Report of a Genetic Diagnosis Made 30 Years Later. J Genet Couns 2017;26:894-901. [PMID: 28612151 DOI: 10.1007/s10897-017-0119-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
66 Grady MC, Kolla KA, Peshkin BN. Multigene Cancer Panels: Implications for Pre- and Post-test Genetic Counseling. Curr Genet Med Rep 2019;7:169-79. [DOI: 10.1007/s40142-019-00173-8] [Reference Citation Analysis]
67 Cardoso F, Bese N, Distelhorst SR, Bevilacqua JL, Ginsburg O, Grunberg SM, Gralla RJ, Steyn A, Pagani O, Partridge AH, Knaul FM, Aapro MS, Andersen BL, Thompson B, Gralow JR, Anderson BO. Supportive care during treatment for breast cancer: resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast 2013;22:593-605. [PMID: 24001709 DOI: 10.1016/j.breast.2013.07.050] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
68 Schuurman AG, van der Kolk DM, Verkerk MA, Birnie E, Ranchor AV, Plantinga M, van Langen IM. Maximising the efficiency of clinical screening programmes: balancing predictive genetic testing with a right not to know. Eur J Hum Genet 2015;23:1124-8. [PMID: 25564039 DOI: 10.1038/ejhg.2014.269] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
69 van der Giessen JAM, van Riel E, Velthuizen ME, van Dulmen AM, Ausems MGEM. Referral to cancer genetic counseling: do migrant status and patients' educational background matter? J Community Genet 2017;8:303-10. [PMID: 28868568 DOI: 10.1007/s12687-017-0326-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
70 Buchanan AH, Voils CI, Schildkraut JM, Fine C, Horick NK, Marcom PK, Wiggins K, Skinner CS. Adherence to Recommended Risk Management among Unaffected Women with a BRCA Mutation. J Genet Couns 2017;26:79-92. [PMID: 27265406 DOI: 10.1007/s10897-016-9981-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
71 Senter L. Hereditary breast and ovarian cancer syndrome: considering the complexities. Curr Probl Cancer 2014;38:226-34. [PMID: 25497409 DOI: 10.1016/j.currproblcancer.2014.10.003] [Reference Citation Analysis]
72 Komenaka IK, Nodora JN, Madlensky L, Winton LM, Heberer MA, Schwab RB, Weitzel JN, Martinez ME. Participation of low-income women in genetic cancer risk assessment and BRCA 1/2 testing: the experience of a safety-net institution. J Community Genet 2016;7:177-83. [PMID: 26690931 DOI: 10.1007/s12687-015-0257-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
73 Catana A, Apostu AP, Antemie RG. Multi gene panel testing for hereditary breast cancer - is it ready to be used? Med Pharm Rep 2019;92:220-5. [PMID: 31460501 DOI: 10.15386/mpr-1083] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
74 Wolfe Schneider K, Anguiano A, Axell L, Barth C, Crow K, Gilstrap M, Hamlington BA, Lesh S, Mullineaux L, Rahm AK, Strait E, Freivogel M. Collaboration of colorado cancer genetic counselors to integrate next generation sequencing panels into clinical practice. J Genet Couns 2014;23:640-6. [PMID: 24781714 DOI: 10.1007/s10897-014-9718-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
75 Berliner JL, Cummings SA, Boldt Burnett B, Ricker CN. Risk assessment and genetic counseling for hereditary breast and ovarian cancer syndromes-Practice resource of the National Society of Genetic Counselors. J Genet Couns 2021;30:342-60. [PMID: 33410258 DOI: 10.1002/jgc4.1374] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 White VB, Walsh KK, Foss KS, Amacker-north L, Lenarcic S, Mcneely L, White RL. Genetic Testing for Hereditary Breast Cancer: The Decision to Decline. The American Surgeon 2018;84:154-60. [DOI: 10.1177/000313481808400139] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
77 Kwong A, Cheng KD, Hsue CV, Hui SK, Leung CR, Leung KA, Ngan KR, Soong SI. BRCA mutation testing for ovarian cancer in the context of available targeted therapy: Survey and consensus of Hong Kong specialists. Asia Pac J Clin Oncol 2019;15 Suppl 2:20-31. [PMID: 30838787 DOI: 10.1111/ajco.13116] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]